Basic Information
| LncRNA/CircRNA Name | onclncRNA-626 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | gastric cancer |
| ICD-0-3 | C16 |
| Methods | PCR, Western blot |
| Sample | GC tissues,cell lines |
| Expression Pattern | up-regulated |
| Function Description | onclncRNA-626 promotes GC progression by binding SRSF1; further, this lncRNA is a potential prognostic biomarker for GC patients. |
| Pubmed ID | 31720086 |
| Year | 2019 |
| Title | OnclncRNA-626 promotes malignancy of gastric cancer via inactivated the p53 pathway through interacting with SRSF1 |
External Links
| Links for onclncRNA-626 | GenBank HGNC NONCODE |
| Links for gastric cancer | OMIM COSMIC |